7 Cap Table Mistakes Solo Founders Make (and Fixes)

Investors can tolerate imperfect decks, but they will not tolerate cap table confusion. A messy cap table signals operational chaos — and it's one of the most common reasons investor due diligence stalls. Here are seven mistakes that repeatedly hurt solo founders, with detailed fixes for each.

1) Mixing percentages and share counts

This is the most common mistake and the most dangerous. Founders say "I own 80% and my advisor has 5%," but when you ask how many shares are issued, they can't answer. Percentages shift with every new issuance — they're a derived metric, not a source of truth. If you promise an advisor "5%" and later issue shares for an option pool, that 5% silently dilutes, creating confusion and potential legal disputes.

Fix: Record everything in share counts. Authorise a fixed number of shares (e.g., 10,000,000), issue shares from that pool, and let percentages calculate automatically. When you tell someone they have 500,000 shares out of 10,000,000, the maths is unambiguous. Tools and spreadsheets should show both, but shares are the primary record.

2) No clear option pool assumptions

Investors will almost always require an option pool as part of a funding round — typically 10–20% of fully diluted shares. The critical question is whether that pool is carved out pre-money or post-money. Pre-money means the pool dilutes existing shareholders (you) before the investor's money is factored in. Post-money means everyone shares the dilution. The difference can be 5–10% of your ownership.

Fix: Before any term sheet conversation, model both scenarios. Know exactly how a 10%, 15%, or 20% pool affects your ownership under pre-money and post-money allocation. Present the model to investors proactively — it shows you understand dilution mechanics and prevents surprises at closing.

3) Missing vesting details

Founders often track that someone "has options" without recording the vesting schedule, cliff dates, exercise price, or acceleration terms. When an early employee leaves and asks what they're owed, the founder scrambles to reconstruct terms from old emails. During due diligence, investors will ask for a complete vesting schedule for every grant — if you can't produce one, it raises red flags.

Fix: For every equity grant, record: grant date, number of shares/options, exercise price, vesting schedule (typically 4-year with 1-year cliff), any acceleration clauses (single or double trigger), and expiration date. Update the vested/unvested split monthly. Link each entry to the signed option agreement.

4) Historical edits without audit history

Founders update their cap table spreadsheet and overwrite previous values. Three years later, no one can reconstruct why the share count changed in Q2 2024 or who approved a particular grant. This makes due diligence painful — lawyers will ask for board resolutions and written consents for every equity issuance, and you won't be able to match them to the cap table entries.

Fix: Maintain a changelog for every cap table modification: what changed, when, why, and the authorising document (board resolution, written consent, subscription agreement). Never overwrite — append. If you're using a spreadsheet, keep a "History" tab. Better yet, use a system that creates audit-trail entries automatically with timestamps and document links.

5) SAFE/convertible assumptions not reconciled

SAFEs and convertible notes don't show up on your cap table as equity until they convert — but they absolutely affect your dilution. A founder with £500k in SAFEs outstanding may think they own 100% of the company, but at conversion those SAFEs could represent 15–25% of fully diluted shares depending on the valuation cap and any discounts. If you have multiple SAFEs with different caps, the conversion maths gets complicated quickly.

Fix: Maintain scenario models that show what happens when each SAFE or convertible note converts. Model different valuation scenarios — what if you raise at £2M? £4M? £8M? — and see how each cap and discount affects your dilution. Present the "worst case" (all instruments converting at the most founder-dilutive terms) alongside the expected case. Investors appreciate founders who understand their own dilution.

6) Legal docs not linked to entries

The cap table says "500,000 shares issued to Jane Smith" but there's no signed subscription agreement, no board resolution approving the issuance, and no evidence of payment. Legally, those shares may not be validly issued. During fundraising, a buyer's or investor's lawyer will request supporting documentation for every material equity event — and if it's missing, you'll need to retroactively create and sign documents, which is messy, time-consuming, and signals poor governance.

Fix: For every cap table entry, link the corresponding signed documents: share subscription agreements, option grant letters, board resolutions, exercise notices, transfer agreements, and SAFE instruments. Store these in your deal room alongside the cap table. When an investor asks "show me the documentation for this issuance," the answer should be one click away.

7) No round-readiness review cycle

Most founders only look at their cap table when they're about to raise. By then, months of changes have accumulated without review — unsigned documents, unrecorded grants, option exercises that weren't logged, and departed team members whose equity status is unclear. Cleaning this up under fundraising time pressure is stressful and delays your close.

Fix: Run a monthly 30-minute cap table review: verify all entries match signed documents, update vesting schedules, reconcile any SAFEs or convertibles, and flag items needing attention. Before a raise, run a full pre-raise validation checklist (see below). This keeps your cap table continuously investor-ready rather than requiring a last-minute scramble.

Round-readiness checklist